PSA Screening – Cancer Treatment at NJU
PSA Testing for Prostate Cancer at New Jersey Urology
Excluding skin cancer, prostate cancer is the most common cancer in men. PSA screening is the best tool currently available for detecting prostate cancer. It is recommended that men age 40 and older who have a life expectancy of 10 years or greater undergo PSA screenings.
PSA testing provides valuable information in the diagnosis, pre-treatment staging, risk assessment, and monitoring of prostate cancer patients. PSA screening has resulted in detecting prostate cancer in its earliest and most curable stages, before it has a chance to spread and potentially become incurable. PSA screening has unequivocally reduced metastatic prostate cancer and death from prostate cancer.
LEADING THE WAY IN CANCER CARE
New Jersey Urology is leading the way in cancer care, from diagnosis through treatment. Dedicated to providing cutting-edge cancer treatment, our Cancer Treatment Centers specialize in the latest therapies and advanced techniques to treat urologic cancers. We offer the most comprehensive medical oncology and advanced radiation therapy in a safe, state-of-the-art environment.
If you believe you may benefit from a PSA screening, you can request an appointment with the button below or contact form. You can also call one of our six leading-edge cancer treatment centers directly by phone via the phone numbers at the bottom of this page.
Diagnosing Prostate Cancer
PSA tests are commonly used as a part of a comprehensive approach to early prostate cancer detection. You doctor may also recommend a Digital Rectal Exam as part of a screening process:
- Prostate-Specific Antigen (PSA) Test – The PSA test is a blood sample that is taken to analyze the levels of PSA in the bloodstream. If the level is high, it may be an indication that the prostate is inflamed, infected, enlarged or cancerous.
- Digital Rectal Exam (DRE) – During a DRE, the physician will insert a gloved, lubricated finger into the rectum to feel for any irregularities (e.g., change in shape, size or texture) in the prostate.
If an abnormality is detected on a DRE or a PSA test, additional testing is required to confirm a diagnosis. Tests may include a transrectal ultrasound—where a probe is inserted into the rectum—or taking a sample of prostate tissue (biopsy) using a thin needle.
Once a cancer diagnosis is confirmed, a physician will determine which stage the cancer is in and begin discussing treatment options.
Download “Prostate Cancer and PSA Screenings” Brochure
Why Do Cancer Patients Entrust Their Care to NJU?
The Cancer Treatment Centers at New Jersey Urology offer comprehensive, leading-edge medical oncology and the most advanced radiation therapy in a safe, state-of-the-art environment for the most effective cancer treatment. NJU is also a pioneer in advanced techniques and expertise in robotic and laparoscopic surgery for prostate, kidney, and bladder cancers.
As a leader in the treatment of prostate cancer with over 42,000+ patients, our Cancer Treatment Centers provide advanced scientific research and innovative clinical trials, including immunotherapy prostate cancer clinical research studies.
Our mission is to provide state-of-the-art treatment and compassionate, personalized care as we partner together through every step of our patients’ cancer treatment.
OUR PATIENTS SAY IT BEST! MEET MICHAEL SECLI:
To contact NJU, use the contact form on this page for more information, or directly call one of our cancer treatment centers below.
Cancer Treatment Centers
